Protein lactylation in myocardial ischemia-reperfusion injury: mechanisms and therapeutic potential - Takeaways - MDSpire

Protein lactylation in myocardial ischemia-reperfusion injury: mechanisms and therapeutic potential

  • By

  • Hang Zhan

  • Die Li

  • Jiayao He

  • Yuzhuang Hu

  • Wei Jiang

  • Jiayu Zhang

  • Wei Chen

  • Weize Xu

  • July 16, 2026

Share

  • 1

    Myocardial ischemia-reperfusion injury (MIRI) is a significant complication in cardiovascular therapy, often exacerbated by reperfusion itself.

  • 2

    Protein lactylation (Kla) is a post-translational modification linked to lactate metabolism, influencing cardiomyocyte responses to ischemic stress.

  • 3

    Kla affects key biological processes such as apoptosis, inflammation, and cardiac remodeling, highlighting its role in MIRI pathogenesis.

  • 4

    Current literature lacks a comprehensive review on the relationship between Kla and MIRI, indicating a gap in understanding its mechanisms.

  • 5

    Future research should focus on elucidating Kla's role in MIRI to inform the development of novel therapeutic strategies.

Original Source(s)

Related Content